🔎 Trials Near Me

ホーム › 急性リンパ性白血病 › イリノイ州 › Chicago

Chicago、ILにおける急性リンパ性白血病の臨床試験

Chicagoとその周辺地域(約30マイル以内)の拠点で、急性リンパ性白血病に関する19件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト(英語)

ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

被験者募集中観察研究健康なボランティア歓迎
  • Mount Sinai Hospital Medical Center, Chicago
  • John H Stroger Jr Hospital of Cook County, Chicago
  • University of Illinois, Chicago
  • 他1件
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

被験者募集中第1/2相
  • The University of Chicago Medical Center, Chicago
30 Days · 全性別 · 2026/09/16更新 · NCT04065399

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

被験者募集中第1/2相
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
22歳以下 · 全性別 · 2026/08/25更新 · NCT04726241

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

被験者募集中第2相
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
7歳〜25歳 · 全性別 · 2026/08/19更新 · NCT05082519

A Study of CTD402 in T-ALL/LBL Patients

被験者募集中第1/2相
  • University of Chicago, Chicago
1歳以上 · 全性別 · 2026/08/19更新 · NCT07070219

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

被験者募集中観察研究
  • The University of Chicago, Chicago
1 Day – 17 Years · 全性別 · 2026/08/14更新 · NCT06274788

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

被験者募集中第1/2相
  • Research Site, Chicago
12歳以上 · 全性別 · 2026/07/13更新 · NCT07109219

Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia

被験者募集中
  • University of Chicago Medicine Comprehensive Cancer Center, Chicago
15歳以上 · 全性別 · 2026/07/10更新 · NCT06446661

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

被験者募集中観察研究
  • Northwestern Memorial Hospital, Chicago
  • Rush University Medical Center, Chicago
  • University of Illinois at Chicago, Chicago
  • 他2件
全年齢 · 全性別 · 2026/07/06更新 · NCT01351545

Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

被験者募集中
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
14歳以上 · 全性別 · 2026/06/30更新 · NCT03932903

Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia

被験者募集中第1相
  • University of Chicago Medical Center, Chicago
18歳〜39歳 · 全性別 · 2026/06/29更新 · NCT03571321

Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)

被験者募集中第2相
  • University of Chicago Medical Center, Chicago
18歳以上 · 全性別 · 2026/06/05更新 · NCT04747912

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

被験者募集中観察研究
  • Lurie Children's Hospital-Chicago, Chicago
全年齢 · 全性別 · 2026/05/18更新 · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

被験者募集中第1相
  • University of Chicago, Chicago
13歳以上 · 全性別 · 2026/05/05更新 · NCT04771572

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

被験者募集中第1/2相
  • Northwestern, Chicago
12歳以上 · 全性別 · 2026/03/24更新 · NCT04988555

A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

被験者募集中第1/2相
  • University of Chicago Medicine Comprehensive Cancer Center, Chicago
18歳以上 · 全性別 · 2026/03/18更新 · NCT06207123

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

被験者募集中第2相
  • University of Chicago Comprehensive Cancer Center, Chicago
18歳〜54歳 · 全性別 · 2026/03/17更新 · NCT06918431

Venetoclax Basket Trial for High Risk Hematologic Malignancies

被験者募集中第1相
  • Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
1歳〜40歳 · 全性別 · 2026/03/12更新 · NCT05292664

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

被験者募集中第1相
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
1歳〜21歳 · 全性別 · 2024/12/06更新 · NCT05476770

他の都市における急性リンパ性白血病の試験

Chicagoにおける他の研究

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。